Manufacturing Europe
SEE OTHER BRANDS

Your best source on manufacturing news from Europe

Manufacturing Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Manufacturing Europe.

Press releases published on June 16, 2025

Gebbia Media Launches New Sports Division, Expanding Support for Elite Athletes Beyond the Game

Gebbia Media Launches New Sports Division, Expanding Support for Elite Athletes Beyond the Game

NEW YORK and MIAMI, June 16, 2025 (GLOBE NEWSWIRE) -- Gebbia Media, a wholly owned subsidiary of Siebert Financial Corp. (NASDAQ: SIEB), has announced the launch of its Sports Division. The new group will focus on serving the unique needs of elite and …

Gold Digging and Baby Trapping 101 Book Launches July 1 from The Bloodline Alliance

Gold Digging and Baby Trapping 101 Book Launches July 1 from The Bloodline Alliance

SAN FRANCISCO, June 16, 2025 (GLOBE NEWSWIRE) -- Preorder data doesn’t lie: the very predators Grave Robbers and Gold Diggers was written to expose are outbuying men 4 to 1. So The Bloodline Alliance did the unthinkable — they handed those predators the …

Phathom Pharmaceuticals Announces FDA Correction to Orange Book Listing, Confirming 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets Through May 3, 2032

Phathom Pharmaceuticals Announces FDA Correction to Orange Book Listing, Confirming 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets Through May 3, 2032

FLORHAM PARK, N.J., June 16, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that the U.S. …

MBX Biosciences Announces IND Submission of MBX 4291, its Long-acting GLP1/GIP Receptor Co-agonist Prodrug for the Treatment of Obesity

MBX Biosciences Announces IND Submission of MBX 4291, its Long-acting GLP1/GIP Receptor Co-agonist Prodrug for the Treatment of Obesity

GLP-1/GIP receptor co-agonist designed to be highly potent and for once-monthly administration based on MBX’s novel PEP™ platform technology Phase 1 trial of MBX 4291 is expected to initiate in Q3 2025 CARMEL, Ind., June 16, 2025 (GLOBE NEWSWIRE) -- MBX …

Quantic X-Microwave Launches Newly Enhanced Layout Tool for RF Designers

Quantic X-Microwave Launches Newly Enhanced Layout Tool for RF Designers

AUSTIN, Texas, June 16, 2025 (GLOBE NEWSWIRE) -- Quantic X-Microwave®, a business of Quantic Electronics® (“Quantic”) and leading provider of RF …

Monarch Private Capital Releases 2024 Impact Report: “Touchpoints”

Monarch Private Capital Releases 2024 Impact Report: “Touchpoints”

ATLANTA, June 16, 2025 (GLOBE NEWSWIRE) -- Monarch Private Capital (Monarch), a nationally recognized impact investment firm that develops, finances, and manages a diversified portfolio of projects generating both federal and state tax credits, is proud to …

X4 Pharmaceuticals Presents Positive Phase 2 Chronic Neutropenia Trial Data in Poster Presentations at the 30th Annual Congress of the European Hematology Association (EHA)

X4 Pharmaceuticals Presents Positive Phase 2 Chronic Neutropenia Trial Data in Poster Presentations at the 30th Annual Congress of the European Hematology Association (EHA)

Poster #1654 highlights clinically meaningful and durable increases in circulating neutrophils observed with mavorixafor treatment +/- G-CSF over 6-month study Poster #1669 highlights findings that investigators were willing and able to reduce injectable G …

Kids Help Phone (KHP) Presents the Next Chapter of Feel Out Loud — Canada’s Largest Youth Mental Health Movement

Kids Help Phone (KHP) Presents the Next Chapter of Feel Out Loud — Canada’s Largest Youth Mental Health Movement

TORONTO, June 16, 2025 (GLOBE NEWSWIRE) -- Today, Kids Help Phone announces the next evolution of Canada’s largest youth mental health movement. Powered by new insights from more than 50 million real-time, real-language, geographically tagged data points …

Jeunesse, J’écoute (JJE) présente le nouveau chapitre de Libère tes émotions, le plus grand mouvement pour la santé mentale des jeunes au Canada

Jeunesse, J’écoute (JJE) présente le nouveau chapitre de Libère tes émotions, le plus grand mouvement pour la santé mentale des jeunes au Canada

TORONTO, 16 juin 2025 (GLOBE NEWSWIRE) -- Aujourd’hui, Jeunesse, J’écoute dévoile la prochaine étape du plus grand mouvement pour la santé mentale des jeunes au Canada. Alimenté par des données inédites (plus de 50 millions de points d’information en temps …

Enphase Energy Rolls Out IQ Battery 5P with FlexPhase, Delivering Three-Phase Backup Across More European Countries

Enphase Energy Rolls Out IQ Battery 5P with FlexPhase, Delivering Three-Phase Backup Across More European Countries

FREMONT, Calif., June 16, 2025 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced the launch of its most powerful …

Bitcoin Solaris Enters Final Weeks of Presale with Mobile Mining, 100,000 TPS, and $20 Launch Price Ahead

Bitcoin Solaris Enters Final Weeks of Presale with Mobile Mining, 100,000 TPS, and $20 Launch Price Ahead

TALLINN, Estonia, June 16, 2025 (GLOBE NEWSWIRE) -- The countdown has begun. Bitcoin Solaris (BTC-S), a next-generation blockchain project engineered for speed, fairness, and global accessibility, is now in Phase 8 of its presale, with just under seven …

ParaZero Demonstrates 50 Successful DropAir Deployments as Part of a Decisive Reproducibility Test

ParaZero Demonstrates 50 Successful DropAir Deployments as Part of a Decisive Reproducibility Test

Kfar Saba, Israel, June 16, 2025 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace company focused on safety systems for commercial unmanned aerial systems and counter UAS systems, today announced the …

TEGNA Announces Major Local News Expansion: Adding More than 100 Hours of New Daily Programming Across 50+ Markets

TEGNA Announces Major Local News Expansion: Adding More than 100 Hours of New Daily Programming Across 50+ Markets

TYSONS, Va., June 16, 2025 (GLOBE NEWSWIRE) -- TEGNA Inc. (NYSE: TGNA) today announced that its stations will be significantly expanding their already substantial local news programming by launching live and on-demand, local newscasts from 7 to 9 a.m. …

NFI subsidiary New Flyer signs a major contract with New Jersey Transit for up to 750 buses

NFI subsidiary New Flyer signs a major contract with New Jersey Transit for up to 750 buses

ST. CLOUD, Minn., June 16, 2025 (GLOBE NEWSWIRE) -- (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (NFI, or the Company) a leader in innovative, propulsion-agnostic bus and coach mobility solutions, subsidiary New Flyer of America Inc. (New Flyer), …

Ocugen, Inc. Announces U.S. FDA Clearance of Investigational New Drug Amendment to Initiate Phase 2/3 Pivotal Confirmatory Clinical Trial of OCU410ST—Modifier Gene Therapy Candidate for Stargardt Disease

Ocugen, Inc. Announces U.S. FDA Clearance of Investigational New Drug Amendment to Initiate Phase 2/3 Pivotal Confirmatory Clinical Trial of OCU410ST—Modifier Gene Therapy Candidate for Stargardt Disease

MALVERN, Pa., June 16, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared …

Fury Finalizes Drill Targeting at its Newly Acquired Sakami Gold Project

Fury Finalizes Drill Targeting at its Newly Acquired Sakami Gold Project

TORONTO, June 16, 2025 (GLOBE NEWSWIRE) -- Fury Gold Mines Limited (TSX and NYSE American: FURY) (“Fury” or the “Company”) is pleased to announce that is has finalized a number of drill targets at the Sakami gold project located in the Eeyou Istchee …

Axsome Therapeutics Proudly Supports Migraine and Headache Awareness Month Alongside the Association of Migraine Disorders

Axsome Therapeutics Proudly Supports Migraine and Headache Awareness Month Alongside the Association of Migraine Disorders

NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, is proud to recognize Migraine and Headache Awareness Month …

iBio Initiates Non-Human Primate Study of First-in-Class Activin E Antibody Following Positive Preclinical Data Demonstrating Prevention in Weight Regain After GLP-1 Treatment

iBio Initiates Non-Human Primate Study of First-in-Class Activin E Antibody Following Positive Preclinical Data Demonstrating Prevention in Weight Regain After GLP-1 Treatment

iBio nominates IBIO-610 as development candidate for its first-in-class Activin E antibody New study aims to evaluate the half-life of IBIO-610 in obese, elderly non-human primates (NHP) and assess early signs of efficacy on fat reduction and body …

Blue Moon Metals Completes First Blast on Nussir Access Portal Ahead of Schedule

Blue Moon Metals Completes First Blast on Nussir Access Portal Ahead of Schedule

TORONTO, June 16, 2025 (GLOBE NEWSWIRE) -- Blue Moon Metals Inc. (“Blue Moon” or the “Company”) (TSXV: MOON; OTCQX: BMOOF), is pleased to announce that the company has commenced underground construction on the Nussir Mine completing the first blast on the …

Exploring Changzhou's Life Aesthetics Along Grand Canal

Exploring Changzhou's Life Aesthetics Along Grand Canal

CHANGZHOU, China, June 16, 2025 (GLOBE NEWSWIRE) -- On June 10, the event "An Encounter with Chinese Culture: Jiangsu Week of the Grand Canal Culture" was held in Brussels, home to the headquarters of the European Union. With the Grand Canal as a symbolic …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service